-
GSK126: A State-Sensitive EZH2 Assay Strategy
2026-08-31
GSK126 is more than an EZH2 inhibitor: it is a powerful probe for separating PRC2 catalytic activity from EZH2 protein abundance. This guide connects oncology assays with a landmark lncRNA study to improve experimental interpretation in cancer epigenetics research.
-
Safe DNA Gel Stain for Safer Nucleic Acid Workflows
2026-08-31
Safe DNA Gel Stain combines sensitive DNA and RNA gel visualization with blue-light compatibility, making it useful for cloning, PCR, RNA analysis, and assay development. Its in-gel and post-electrophoresis formats help laboratories balance band recovery, DNA damage reduction during gel imaging, and practical workflow control.
-
Bobcat339 and the Epigenetic Logic of Osteogenesis
2026-08-30
A translational framework for using Bobcat339 to test how TET-dependent DNA demethylation intersects with UHRF1, super-enhancers, TGM2, and osteogenic failure in senile osteoporosis.
-
Phillygenin in Diabetic Nephropathy: Mechanistic Evidence
2026-08-29
The reference study shows that phillygenin reduces hyperglycemia-associated inflammation, apoptosis, podocyte injury, and albuminuria through coordinated changes in the TLR4/MyD88/NF-κB and PI3K/AKT/GSK3β signaling axes. Its integrated cell and mouse experiments provide a mechanistic preclinical basis for studying phillygenin in diabetic kidney disease, while also highlighting the need for stronger causal and translational validation.
-
Hoechst 33342 for GERD Cell Assay Workflows
2026-08-28
Use Hoechst 33342 to add a fast, quantitative nuclear readout to bile acid-stressed epithelial models, apoptosis experiments, and pathway-focused imaging. This workflow shows how nuclear morphology and cell counts can complement the inflammatory and barrier measurements used in GERD research.
-
Oridonin, Inflammation, and Esophageal Cancer
2026-08-28
Peng et al. show that oridonin reduces inflammatory, pathological, hematological, and tumor-associated changes in a 4-NQO-induced mouse model of esophageal cancer, with effects aligned to suppression of the TLR4/NF-κB/NLRP3 inflammasome axis. The study provides a useful multi-readout framework for investigating inflammation-linked tumor biology, while its animal design and lack of direct pathway-intervention experiments limit causal and clinical interpretation.
-
Epigenetic Immune Signatures in Melanoma
2026-08-27
Anichini and colleagues compared several epigenetic drug classes in melanoma and found that the DNMT inhibitor guadecitabine most consistently induced tumor-cell immune programs linked to innate sensing and interferon signaling. By integrating cell-line experiments, protein validation, patient biopsies, xenograft data, and TCGA analyses, the study identifies epigenetic immune priming as a rational strategy for improving checkpoint-blockade responses.
-
Hoechst 33342 for Dermal Fibroblast Senescence
2026-08-27
Hoechst 33342 provides a practical nuclear readout for live-cell imaging, fixed-cell immunofluorescence, and flow cytometry in dermal fibroblast aging studies. Its membrane permeability and simple dilution workflow make it useful for connecting cell counts and nuclear morphology with senescence, mitochondrial quality, and mitophagy assays.
-
DAF-2 diacetate: Reliable NO Assays
2026-08-26
Learn how DAF-2 diacetate, SKU C4210, can strengthen live-cell nitric oxide imaging and complement viability, proliferation, and cytotoxicity workflows. This scenario-based guide covers probe chemistry, protocol optimization, controls, interpretation, cross-domain applications, and practical vendor selection.
-
Mitoxantrone Targets the ERα DBD–LBD Interface
2026-08-26
Wang and colleagues identify mitoxantrone as an allosteric ligand of the ERα DNA-binding domain–ligand-binding domain interface, revealing a mechanism distinct from conventional hormone-pocket antagonism and Topo-II-mediated DNA damage. The study shows that this interaction promotes receptor redistribution and proteasomal degradation, including in endocrine therapy-resistant ERα mutant models.
-
PDHA1 Succinylation and Immune Escape in Cholangiocarcinoma
2026-08-25
The reference study identifies PDHA1 lysine 83 succinylation as a metabolic–immune switch in cholangiocarcinoma: increased PDH activity drives α-ketoglutarate accumulation, activates macrophage OXGR1–MAPK signaling, and suppresses MHC-II antigen presentation. Its findings provide a mechanistic rationale for testing succinylation inhibition alongside gemcitabine and cisplatin, while clinical validation and more selective pharmacology remain necessary.
-
Nanobody-TurboID Maps the CD38 Surfaceome
2026-08-25
Feng and colleagues introduce nanobody-targeted TurboID (NBID) to profile proteins positioned near CD38 on living cell surfaces. Their proteomic, imaging, and migration data connect CD38 with adhesion-related membrane networks and tumor–endothelial interactions, while also establishing a general strategy for studying surface-protein neighborhoods.
-
S-Adenosylhomocysteine in Radiation-Neural Assays
2026-08-24
S-Adenosylhomocysteine (SAH) provides a mechanistic way to study methyltransferase inhibition and SAM/SAH ratio modulation alongside radiation-induced neural differentiation. This article translates a seminal C17.2-cell study into a rigorous assay framework while clearly separating established evidence from testable metabolic hypotheses.
-
iPSC Models for Cystic Fibrosis Drug Testing
2026-08-24
The reference study developed a multimodal induced pluripotent stem cell platform that generates airway epithelial models from individuals carrying common or rare CFTR variants. By combining 3D forskolin-induced spheroid swelling with 2D polarized mucociliary cultures, the platform detected genotype-specific baseline function and modulator responses, supporting translational testing for variants that remain poorly served by current therapies.
-
6-FAM SE for Durable Molecular Labeling
2026-08-23
6-FAM SE combines amine-selective coupling with durable fluorescein-based detection for DNA, peptides, proteins, and engineered nanomedicine assays. This practical guide covers reaction setup, label-to-substrate optimization, purification, controls, and how to adapt the chemistry for tracking stimulus-responsive systems.